AI Drug Discovery's Evidence Gap
Billions have flowed into AI drug discovery with zero FDA approvals, and the bottleneck is evidence infrastructure, not molecule generation.
Billions have flowed into AI drug discovery with zero FDA approvals, and the bottleneck is evidence infrastructure, not molecule generation.
Agentic AI that extracts and standardizes EHR data for oncology trial matching is becoming clinical trial infrastructure with no validation framework behind it.